等待开盘 08-25 09:30:00 美东时间
-0.210
-1.00%
今日重点评级关注:Canaccord Genuity:维持Cardiol Therapeutics"买入"评级,目标价从8美元升至10美元;B. Riley证券:维持Macrogenics"买入"评级,目标价从9美元升至11美元
08-18 11:39
An update from First Advantage ( ($FA) ) is now available. On August 10, 2026, ...
08-13 05:29
First Advantage Corporation (FA) on Monday announced the pricing of the previously announced underwritten secondary offering of 12.50M shares of its common stock at a price of $22.20 per share. The of...
08-11 21:20
FIRST ADVANTAGE CORPORATION Common Stock This prospectus relates to the offer and sale from time to time of up to 87,450,000 shares of First Advantage Corporation common stock, par value $0.001 per share, by the selling stockholder identified in this prospectus or in supplements to this prospectus. ...
08-11 05:14
今日重点评级关注:康托·菲茨杰拉德:维持EyePoint"超配"评级,目标价从47美元升至55美元;伯恩斯坦:维持Figure Technology"跑赢大市"评级,目标价从67美元升至70美元
08-07 13:41
今日重点评级关注:HC Wainwright & Co.:维持Enlivex"买入"评级,目标价从20美元升至80美元;Canaccord Genuity:维持Pharming Group NV Sponsored ADR"买入"评级,目标价从37美元升至38美元
08-04 11:45
RBC Capital analyst Ashish Sabadra maintains First Advantage (NASDAQ:FA) with a Sector Perform and raises the price target from $17 to $21.
08-03 23:34
First Advantage Corporation has been named #1 in Background Screening and Identity Verification on TIME’s 2026 list of America’s Best Companies, ranking among the top 25 in Professional Services. The recognition, in collaboration with Statista, evaluates Employee Satisfaction, Financial Performance, and Sustainability Transparency. First Advantage also ranks in the top three Professional Services companies by financial performance. CEO Scott Stap...
07-21 20:05
First Advantage Corporation (NASDAQ: FA), a global software and data company, will release its Q2 2026 financial results on August 6, 2026, followed by an earnings conference call at 8:30 a.m. ET. Participants can join via phone or webcast at investors.fadv.com. A replay will be available post-call. First Advantage provides identity solutions, background screening, and risk monitoring, serving over 80,000 global customers.
07-16 11:00
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从9美元升至11美元;康托·菲茨杰拉德:维持Artiva Biotherapeutics"超配"评级,目标价从10美元升至40美元
05-12 12:36